The Krascendo 1 study showed improved survival rates of 18 months compared to 12 months with current standard of care ...

MAD World Summit 2026 has secured official accreditation from The CPD Group, strengthening its position as a must-attend ...

AbbVie has announced results from the ongoing phase 3 Viti-Up-1 and Viti-Up-2 studies of Rinvoq (upadacitinib; 15mg once ...

Understanding how AI decisions are made, who owns the outcomes and how accountability travels across partners and platforms ...

Over the past decades, advances in information technology have fundamentally transformed the management of chronic diseases, ...

In the third issue of The Vector, Genesis Research asked 15 payers across France, Germany, Italy, Spain, and the UK how they ...

NSV is a chronic autoimmune disease where the immune system attacks melanin-producing cells, leading to a loss of pigment ...

Logistical challenges are not new in clinical research, from the high cost of developing new therapies to complexities in ...

AstraZeneca has announced the opening of its newest global strategic research and development (R&D) centre, in Kendall Square, Cambridge, Massachusetts, US. The new state-of- the-art facility builds ...

The UK has the science, policy ambition and institutions to become a global life sciences leader. Here, the authors discuss why this moment feels different. Together, they explain why health is an ...

At EHA 2026 in Stockholm, 425 hematologists and oncologists attended an independent, 90-minute Medscape symposium on the practical and ethical use of AI. The format was case-based. The faculty ...